The COAPT Trial is a clinical trial designed to study the safety and effectiveness of the MitraClip® device in heart failure patients who have functional mitral regurgitation (MR) and are not appropriate for mitral value surgery.

We welcome you to learn more about the trial, patient eligibility and participating trial sites.

About the COAPT Trial »

Introducing the COAPT Trial Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation